Table 1 The clinical data of the study population (n/IQR, P)
Characteristic | Total (n = 563) | Non-MPP (n = 376) | MPP (n = 187) | P |
|---|---|---|---|---|
Gender Male | 332 | 225 | 107 | 0.552 |
Female | 231 | 151 | 80 | Â |
Age (M) | 36 [12, 60] | 24 [12, 48] | 48 [24, 84] | < 0.01 |
hsCRP (mg/L) | 5.1 [0.78, 22.1] | 4.05 [0.78, 20.2] | 8.19 [2.42, 27.83] | < 0.01 |
PCT (ng/mL) | 0.1 [0.06, 0.23] | 0.1 [0.06, 0.23] | 0.09 [0.06, 0.19] | 0.185 |
WBC (109/L) | 8.15 [5.98, 10.76] | 8.22 [5.92, 10.83] | 7.6 [6.31, 9.91] | 0.447 |
RBC (1012/L) | 4.49 [4.21, 4.72] | 4.49 [4.23, 4.7] | 4.56 [4.28, 4.85] | < 0.01 |
HGB (g/L) | 121 [114, 128] | 121 [113, 127] | 124 [117, 131] | < 0.01 |
HCT (%) | 36.7 [34.6, 38.7] | 36.7 [34.7, 38.6] | 37.6 [35.3, 39.7] | < 0.01 |
PLT (109/L) | 310.5 [250.25, 400] | 308 [251, 396] | 296 [237, 398] | 0.317 |
NEU (109/L) | 3.42 [2.08, 5.52] | 3.14 [1.86, 5.29] | 4.16 [3.04, 5.77] | < 0.01 |
LYM (109/L) | 3.11 [2.02, 4.71] | 3.36 [2.21, 5.02] | 2.45 [1.78, 3.43] | < 0.01 |
MONO (109/L) | 0.59 [0.38, 0.85] | 0.61 [0.38, 0.87] | 0.52 [0.39, 0.73] | < 0.01 |
EOS (109/L) | 0.1 [0.02, 0.23] | 0.09 [0.02, 0.24] | 0.1 [0.03, 0.23] | 0.344 |
BASO (109/L) | 0.02 [0.01, 0.03] | 0.02 [0.01, 0.03] | 0.01 [0.01, 0.02] | 0.054 |